Work

Supplementary Table 3 from Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer

Year: 2023
Type: supplementary-materials
Abstract: PDF file, 361K, Comparison of EGFR TKI and HSP90 inhibitor efficacy in Ba/F3 cells ectopically expressing different EGFR mutations.
Language: English
Open Access status: gold
OpenAlex ID: W4362393074
Cites:
Cited by:
Related to: 10